Permethrin and ivermectin for scabies

New England Journal of Medicine

Volumn 362, Issue 8, 2010, Pages 717-725

  Currie, Bart J ^a   McCarthy, James S ^b  

^a ROYAL DARWIN HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATHINE PENICILLIN; BENZYL BENZOATE; CORTICOSTEROID; CROTAMITON; IVERMECTIN; LINDANE; MALATHION; PERMETHRIN; SULFUR; TEA TREE OIL;

ANTIMICROBIAL THERAPY; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMA; CONFUSION; CORTICOSTEROID THERAPY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG FEVER; DRUG HALF LIFE; DRUG INDICATION; FOOD; FOOD DRUG INTERACTION; HUMAN; INFECTION PREVENTION; INSECTICIDAL ACTIVITY; INSECTICIDE RESISTANCE; LETHARGY; LOIASIS; MALAISE; MYALGIA; NEUROTOXICITY; ORTHOSTATIC HYPOTENSION; PARASITE TRANSMISSION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRURITUS; PYODERMA; RECOMMENDED DRUG DOSE; SARCOPTES SCABIEI; SCABIES; SCRATCHING; SINGLE DRUG DOSE; SKIN MANIFESTATION;

EID: 77349124256     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMct0910329     Document Type: Article

References (50)

1. Mellanby K. The development of symptoms, parasitic infection and immunity in human scabies. Parasitology 1944; 35:197-206.
2. Chosidow O. Scabies. N Engl J Med 2006;354:1718-27.
3. Green MS. Epidemiology of scabies. Epidemiol Rev 1989;11:126-50.
4. Hengge UR, Currie BJ, Jäger G, Lupi O, Schwartz RA. Scabies: a ubiquitous neglected skin disease. Lancet Infect Dis 2006;6:769-79.
5. Heukelbach J, Feldmeier H. Scabies. Lancet 2006;367:1767-74.
6. Chosidow O. Scabies and pediculosis. Lancet 2000;355:819-26.
7. Scheinfeld N. Controlling scabies in institutional settings: a review of medications, treatment models, and implementation. Am J Clin Dermatol 2004;5:31-7.
8. Buehlmann M, Beltraminelli H, Strub C, et al. Scabies outbreak in an intensive care unit with 1,659 exposed individuals - key factors for controlling the outbreak. Infect Control Hosp Epidemiol 2009;30:354-60.
9. McCarthy JS, Kemp DJ, Walton SF, Currie BJ. Scabies: more than just an irritation. Postgrad Med J 2004;80:382-7.
10. Roberts LJ, Huffam SE, Walton SF, Currie BJ. Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature. J Infect 2005;50:375-81.
11. Johnston G, Sladden M. Scabies: diagnosis and treatment. BMJ 2005;331:619-22.
12. Strong M, Johnstone PW. Interventions for treating scabies. Cochrane Database Syst Rev 2007;3:CD000320.
13. Walton SF, Myerscough MR, Currie BJ. Studies in vitro on the relative efficacy of current acaricides for Sarcoptes scabiei var. hominis. Trans R Soc Trop Med Hyg 2000;94:92-6.
14. Currie BJ, Harumal P, McKinnon M, Walton SF. First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin Infect Dis 2004;39(1): e8-e12.
15. Zlotkin E. The insect voltage-gated sodium channel as target of insecticides. Annu Rev Entomol 1999;44:429-55.
16. Geary TG. Ivermectin 20 years on: maturation of a wonder drug. Trends Parasitol 2005;21:530-2.
17. Mounsey KE, Dent JA, Holt DC, McCarthy J, Currie BJ, Walton SF. Molecular characterisation of a pH-gated chloride channel from Sarcoptes scabiei. Invert Neurosci 2007;7:149-56.
18. Hu S, Bigby M. Treating scabies: results from an updated Cochrane review. Arch Dermatol 2008;144:1638-40.
19. Ly F, Caumes E, Ndaw CA, Ndiaye B, Mahé A. Ivermectin versus benzyl benzoate applied once or twice to treat human scabies in Dakar, Senegal: a randomized controlled trial. Bull World Health Organ 2009;87:424-30.
20. Usha V, Gopalakrishnan Nair TV. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol 2000;42:236-40.
21. Meinking TL, Taplin D, Hermida JL, Pardo R, Kerdel FA. The treatment of scabies with ivermectin. N Engl J Med 1995; 333:26-30.
22. Huffam SE, Currie BJ. Ivermectin for Sarcoptes scabiei hyperinfestation. Int J Infect Dis 1998;2:152-4.
23. Mumcuoglu KY, Gilead L. Treatment of scabies infestations. Parasite 2008;15: 248-51.
24. Guzzo CA, Furtek CI, Porras AG, et al. Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects. J Clin Pharmacol 2002;42:1122-33.
25. Obasanjo OO, Wu P, Conlon M, et al. An outbreak of scabies in a teaching hospital: lessons learned. Infect Control Hosp Epidemiol 2001;22:13-8.
26. Andersen BM, Haugen H, Rasch M, Heldal Haugen A, Tageson A. Outbreak of scabies in Norwegian nursing homes and home care patients: control and prevention. J Hosp Infect 2000;45:160-4.
27. Paasch U, Haustein UF. Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin. Int J Dermatol 2000;39:463-70.
28. Jimenez-Lucho VE, Fallon F, Caputo C, Ramsey K. Role of prolonged surveillance in the eradication of nosocomial scabies in an extended care Veterans Affairs medical center. Am J Infect Control 1995;23:44-9.
29. Yonkosky D, Ladia L, Gackenheimer L, Schultz MW. Scabies in nursing homes: an eradication program with 5% permethrin cream. J Am Acad Dermatol 1990;23:1133-6.
30. Sullivan JR, Watt G, Barker B. Successful use of ivermectin in the treatment of endemic scabies in a nursing home. Australas J Dermatol 1997;38:137-40.
31. Dannaoui E, Kiazand A, Piens M, Picot S. Use of ivermectin for the management of scabies in a nursing home. Eur J Dermatol 1999;9:443-5.
32. Leppard B, Naburi AE. The use of ivermectin in controlling an outbreak of scabies in a prison. Br J Dermatol 2000;143: 520-3.
33. Flinders DC, de Schweinitz P. Pediculosis and scabies. Am Fam Physician 2004; 69:341-8.
34. Owusu-Edusei K, Chesson HW, Gift TL. The economic burden of pediculosis pubis and scabies infections treated on an outpatient basis in the United States: evidence from private insurance claims data, 2001-2005. Sex Transm Dis 2009;36: 297-9.
35. Tomalik-Scharte D, Lazar A, Meins J, et al. Dermal absorption of permethrin following topical administration. Eur J Clin Pharmacol 2005;61:399-404.
36. Basáñez MG, Pion SD, Boakes E, Filipe JA, Churcher TS, Boussinesq M. Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and metaanalysis. Lancet Infect Dis 2008;8:310-22.
37. Twum-Danso NA. Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases. Filaria J 2003;2:Suppl 1:S3.
38. Mackenzie CD, Geary TG, Gerlach JA. Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients. Filaria J 2003;2:Suppl 1:S5.
39. Pacqué M, Muñoz B, Poetschke G, Foose J, Greene BM, Taylor HR. Pregnancy outcome after inadvertent ivermectin treatment during community-based distribution. Lancet 1990;336:1486-9.
40. Chippaux JP, Gardon-Wendel N, Gardon J, Ernould JC. Absence of any adverse effect of inadvertent ivermectin treatment during pregnancy. Trans R Soc Trop Med Hyg 1993;87:318.
41. Gyapong JO, Chinbuah MA, Gyapong M. Inadvertent exposure of pregnant women to ivermectin and albendazole during mass drug administration for lymphatic filariasis. Trop Med Int Health 2003;8:1093-101.
42. Pasay C, Arlian L, Morgan M, et al. High-resolution melt analysis for the detection of a mutation associated with permethrin resistance in a population of scabies mites. Med Vet Entomol 2008;22:82-8.
43. Pasay C, Arlian L, Morgan M, et al. The effect of insecticide synergists on the response of scabies mites to pyrethroid acaricides. PLoS Negl Trop Dis 2009;3(1): e354.
44. Edwards G. Ivermectin: does P-glyco-protein play a role in neurotoxicity? Filaria J 2003;2:Suppl 1:S8.
45. Barkwell R, Shields S. Deaths associated with ivermectin treatment of scabies. Lancet 1997;349:1144-5.
46. Coyne PE, Addiss DG. Deaths associated with ivermectin for scabies. Lancet 1997;350:215-6.
47. Diazgranados JA, Costa JL. Deaths after ivermectin treatment. Lancet 1997;349: 1698.
48. Reintjes R, Hoek C. Deaths associated with ivermectin for scabies. Lancet 1997; 350:215.
49. del Mar Sáez-De-Ocariz M, McKinster CD, Orozco-Covarrubias L, Tamayo-Sánchez L, Ruiz-Maldonado R. Treatment of 18 children with scabies or cutaneous larva migrans using ivermectin. Clin Exp Dermatol 2002;27:264-7.
50. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006;55(RR-11):1-94.